---
layout: post
title: "Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use; Guidance for Industry; Availability"
date: 2026-02-04 21:46:40 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-19990
original_published: 2025-11-17 00:00:00 +0000
significance: 8.00
---

# Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use; Guidance for Industry; Availability

**Published:** February 04, 2026 21:46 UTC
**Source:** Federal Register
**Original Published:** November 17, 2025 00:00 UTC
**Document Number:** 2025-19990

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use." This guidance is intended to assist abbreviated new drug application (ANDA) applicants that reference a drug product intended for parenteral, ophthalmic, or otic use in seeking approval of a drug that is qualitatively (Q1) different or quantitatively (Q2) different from the reference listed drug (RLD) with respect to the pH adjuster(s). This guidance describes how FDA intends to evaluate a request for a waiver of Agency requirements for a Q1 or Q2 difference in pH adjuster, including recommendations on the type of information to provide in support of such a waiver request. This guidance finalizes the draft guidance of the same title issued on April 14, 2022.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/11/17/2025-19990/considerations-for-waiver-requests-for-ph-adjusters-in-generic-drug-products-intended-for-parenteral)
- API: https://www.federalregister.gov/api/v1/documents/2025-19990

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
